» Articles » PMID: 36119835

Cuproptosis-related Gene SLC31A1 is a Potential Predictor for Diagnosis, Prognosis and Therapeutic Response of Breast Cancer

Overview
Journal Am J Cancer Res
Specialty Oncology
Date 2022 Sep 19
PMID 36119835
Authors
Affiliations
Soon will be listed here.
Abstract

Cuproptosis is a recently reported novel way of cell death. A comprehensive study regarding expression, function and mechanism of cuproptosis-related genes in breast cancer is still absent. In this work, a series of analyses were employed and SLC31A1 was selected as the most potential cuproptosis-related gene in breast cancer, which was statistically upregulated and possessed significant abilities to predict diagnosis, prognosis and drug response. Moreover, SLC31A1 was significantly positively correlated with different immune cell infiltration levels, immune cell biomarkers or immune checkpoints in breast cancer. Upstream G2E3-AS1/let-7a-5p and CDKN2B-AS1/let-7b-5p pathways were found to be responsible for SLC31A1 upregulation in breast cancer based on competing endogenous RNA mechanism. Furthermore, we found that SLC31A1 overexpression might be also induced by its high copy number level in breast cancer. Collectively, our current data elucidated that cuproptosis-related SLC31A1 might be a promising diagnostic/prognostic biomarker and drug responsive predictor in breast cancer.

Citing Articles

Targeting the initiator to activate both ferroptosis and cuproptosis for breast cancer treatment: progress and possibility for clinical application.

Imam M, Ji J, Zhang Z, Yan S Front Pharmacol. 2025; 15:1493188.

PMID: 39867656 PMC: 11757020. DOI: 10.3389/fphar.2024.1493188.


Cuproptosis: molecular mechanisms, cancer prognosis, and therapeutic applications.

Cong Y, Li N, Zhang Z, Shang Y, Zhao H J Transl Med. 2025; 23(1):104.

PMID: 39844182 PMC: 11752808. DOI: 10.1186/s12967-025-06121-1.


Roles of Copper Transport Systems Members in Breast Cancer.

Chen Y, Li C, Li M, Han B Cancer Med. 2024; 13(24):e70498.

PMID: 39676279 PMC: 11646948. DOI: 10.1002/cam4.70498.


Identification and validation of mRNA profiles linked to ATP- induced cell death represent a novel prognostic model for breast cancer.

Zhang Z, Zhang H, Zhang Z, Sandai D, Lu P, Zhang H Front Immunol. 2024; 15:1483498.

PMID: 39555060 PMC: 11563968. DOI: 10.3389/fimmu.2024.1483498.


Cuproptosis, ferroptosis and PANoptosis in tumor immune microenvironment remodeling and immunotherapy: culprits or new hope.

Zhang X, Tang B, Luo J, Yang Y, Weng Q, Fang S Mol Cancer. 2024; 23(1):255.

PMID: 39543600 PMC: 11566504. DOI: 10.1186/s12943-024-02130-8.


References
1.
Lou W, Chen J, Ding B, Fan W . XIAP, commonly targeted by tumor suppressive miR-3607-5p and miR-3607-3p, promotes proliferation and inhibits apoptosis in hepatocellular carcinoma. Genomics. 2021; 113(3):933-945. DOI: 10.1016/j.ygeno.2021.02.003. View

2.
Li T, Fan J, Wang B, Traugh N, Chen Q, Liu J . TIMER: A Web Server for Comprehensive Analysis of Tumor-Infiltrating Immune Cells. Cancer Res. 2017; 77(21):e108-e110. PMC: 6042652. DOI: 10.1158/0008-5472.CAN-17-0307. View

3.
Qin S, Ning M, Liu Q, Ding X, Wang Y, Liu Q . Knockdown of long non-coding RNA CDKN2B-AS1 suppresses the progression of breast cancer by miR-122-5p/STK39 axis. Bioengineered. 2021; 12(1):5125-5137. PMC: 8806778. DOI: 10.1080/21655979.2021.1962685. View

4.
Li S, Bu L, Cai L . Cuproptosis: lipoylated TCA cycle proteins-mediated novel cell death pathway. Signal Transduct Target Ther. 2022; 7(1):158. PMC: 9106713. DOI: 10.1038/s41392-022-01014-x. View

5.
Li C, Tang Z, Zhang W, Ye Z, Liu F . GEPIA2021: integrating multiple deconvolution-based analysis into GEPIA. Nucleic Acids Res. 2021; 49(W1):W242-W246. PMC: 8262695. DOI: 10.1093/nar/gkab418. View